FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
 For Possible Violations of Securities Laws and Delaware Law - EconoTimes)
NEW YORK, Sept. 16, 2016 -- Barrack, Rodos & Bacine is investigating the Board of Directors of Standex International Corp. (“Standex” or the “Company”) for possible violations of securities laws and Delaware law relating to the Proxy Statement the Company filed concerning the upcoming annual shareholder meeting to be held on October 27, 2016.
The Proxy Statement filed by Standex with the U.S. Securities and Exchange Commission on September 9, 2016 recommends that Standex shareholders vote to approve five Company proposals. Barrack, Rodos & Bacine’s investigation of these Company proposals indicates that they may contain misleading information that will inhibit a meaningful stockholder vote.
Holders of Standex stock are encouraged to contact Michael Toomey of Barrack Rodos & Bacine, at the following toll-free number: 877-386-3304, or via e-mail to [email protected].
Barrack Rodos & Bacine has more than three decades of experience prosecuting securities and corporation law actions, and has achieved some of the largest recoveries in the history of such litigation.
Michael Toomey 877-386-3304 [email protected]
